MicroPort CardioFlow Medtech Corporation
Status: Publicly traded
Direct answer
MicroPort CardioFlow Medtech Corporation is publicly traded on HKSE under the ticker 2160.HK.
MicroPort CardioFlow Medtech Corporation is a medical technology firm dedicated to the comprehensive research, development, and commercialization of advanced transcatheter and surgical therapies for structural heart conditions. Operating primarily within the People's Republic of China, its innovative product line includes the Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set,...
Can you invest in MicroPort CardioFlow Medtech Corporation?
Yes. MicroPort CardioFlow Medtech Corporation is publicly traded on HKSE under the ticker 2160.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for MicroPort CardioFlow Medtech Corporation
Detailed equity research is provided by MarketSnap.